102 related articles for article (PubMed ID: 9376479)
41. Prognostic significance of the MUC1 and MUC4 expressions in thyroid papillary carcinoma.
Baek SK; Woo JS; Kwon SY; Lee SH; Chae YS; Jung KY
Laryngoscope; 2007 May; 117(5):911-6. PubMed ID: 17473695
[TBL] [Abstract][Full Text] [Related]
42. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems.
Yildirim E
J Am Coll Surg; 2005 Mar; 200(3):378-92. PubMed ID: 15737848
[TBL] [Abstract][Full Text] [Related]
43. AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma.
Voutilainen PE; Siironen P; Franssila KO; Sivula A; Haapiainen RK; Haglund CH
Anticancer Res; 2003; 23(5b):4283-8. PubMed ID: 14666639
[TBL] [Abstract][Full Text] [Related]
44. Recurrent papillary thyroid cancer: analysis of prognostic factors including the histological variant.
Ortiz S; Rodríguez JM; Parrilla P; Pérez D; Moreno-Gallego A; Rios A; Soria T
Eur J Surg; 2001 Jun; 167(6):406-12. PubMed ID: 11471663
[TBL] [Abstract][Full Text] [Related]
45. Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma.
Akslen LA; LiVolsi VA
Cancer; 2000 Apr; 88(8):1902-8. PubMed ID: 10760768
[TBL] [Abstract][Full Text] [Related]
46. [Influence of lymphocitic thyroiditis on prognostic outcome differentiated thyroid carcinoma].
Filipović A; Paunović I; Vucković Lj
Acta Chir Iugosl; 2010; 57(2):85-94. PubMed ID: 20954315
[TBL] [Abstract][Full Text] [Related]
47. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
Haq M; Harmer C
Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
[TBL] [Abstract][Full Text] [Related]
48. [Cellular immunologic studies in pediatric and juvenile thyroid cancer].
Boros P; Csáky G; Balázs G; Szegedi G
Zentralbl Chir; 1986; 111(19):1179-82. PubMed ID: 3492839
[TBL] [Abstract][Full Text] [Related]
49. Differentiated thyroid carcinoma: comparison between papillary and follicular carcinoma in a single institute.
Chow SM; Law SC; Au SK; Leung TW; Chan PT; Mendenhall WM; Lau WH
Head Neck; 2002 Jul; 24(7):670-7. PubMed ID: 12112541
[TBL] [Abstract][Full Text] [Related]
50. Papillary thyroid carcinoma: factors influencing recurrence and survival.
Toniato A; Boschin I; Casara D; Mazzarotto R; Rubello D; Pelizzo M
Ann Surg Oncol; 2008 May; 15(5):1518-22. PubMed ID: 18324441
[TBL] [Abstract][Full Text] [Related]
51. HLA and thyroid carcinoma.
Ahuja S; Hoppe I; von Keyserlingk H; Ernst H
Exp Clin Endocrinol; 1992; 99(3):134-6. PubMed ID: 1526261
[TBL] [Abstract][Full Text] [Related]
52. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
53. HLA-DR expression and lymphocytic infiltration in metastatic and non-metastatic papillary carcinoma of the thyroid.
Feinmesser M; Stern S; Mechlis-Frish S; Lubin E; Feinmesser R; Kristt D
Eur J Surg Oncol; 1996 Oct; 22(5):494-501. PubMed ID: 8903492
[TBL] [Abstract][Full Text] [Related]
54. Immunogenetic and immunologic studies of differentiated thyroid cancer.
Juhasz F; Boros P; Szegedi G; Balazs G; Suranyi P; Kraszits E; Stenszky V; Farid NR
Cancer; 1989 Apr; 63(7):1318-26. PubMed ID: 2784072
[TBL] [Abstract][Full Text] [Related]
55. Infiltration of a mixture of different immune cells may be related to molecular profile of differentiated thyroid cancer.
Cunha LL; Morari EC; Guihen AC; Razolli D; Gerhard R; Nonogaki S; Soares FA; Vassallo J; Ward LS
Endocr Relat Cancer; 2012 Jun; 19(3):L31-6. PubMed ID: 22461634
[No Abstract] [Full Text] [Related]
56. Predictive relevance of programmed cell death protein 1 and tumor-infiltrating lymphocyte expression in papillary thyroid cancer.
Aghajani MJ; Yang T; McCafferty CE; Graham S; Wu X; Niles N
Surgery; 2018 Jan; 163(1):130-136. PubMed ID: 29128181
[TBL] [Abstract][Full Text] [Related]
57. Thyroid carcinoma. Immunology, irradiation, and lymphocytic infiltration.
Shull JH; Sharon N; Victor TA; Scanlon EF
Arch Surg; 1979 Jun; 114(6):729-31. PubMed ID: 313201
[TBL] [Abstract][Full Text] [Related]
58. In situ evidence of neoplastic cell phagocytosis by macrophages in papillary thyroid cancer.
Fiumara A; Belfiore A; Russo G; Salomone E; Santonocito GM; Ippolito O; Vigneri R; Gangemi P
J Clin Endocrinol Metab; 1997 May; 82(5):1615-20. PubMed ID: 9141559
[TBL] [Abstract][Full Text] [Related]
59. CD8+ tumour-infiltrating lymphocytes and COX2 expression may predict relapse in differentiated thyroid cancer.
Cunha LL; Marcello MA; Nonogaki S; Morari EC; Soares FA; Vassallo J; Ward LS
Clin Endocrinol (Oxf); 2015 Aug; 83(2):246-53. PubMed ID: 25130519
[TBL] [Abstract][Full Text] [Related]
60. [Hürthle cell carcinoma of the thyroid gland].
Svastits E; Tóth K; Besznyák I; Daubner K; Bodó M
Orv Hetil; 1984 Jan; 125(1):5-8. PubMed ID: 6691026
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
